Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other financing activities (2024)

Historic Other financing activities for Immunocore Holdings (IMCR) over the last 1 years, with Q2 2024 value amounting to $1.1 million.

  • Immunocore Holdings' Other financing activities changed N/A to $1.1 million in Q2 2024 from the same period last year, while for Mar 2025 it was $1.1 million, marking a year-over-year decrease of 9088.38%. This contributed to the annual value of $13.4 million for FY2024, which is N/A changed from last year.
  • Per Immunocore Holdings' latest filing, its Other financing activities stood at $1.1 million for Q2 2024.
  • Immunocore Holdings' 5-year Other financing activities high stood at $12.2 million for Q1 2024, and its period low was $1.1 million during Q2 2024.